Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mares

Showing results (231-240 of 236) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 236 results.
European Journal of Neurology|March 3, 2011
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosisA Novotna, J Mares, S Ratcliffe, et al.
Multiple Sclerosis and Related Disorders|August 11, 2019
Initiation of first disease-modifying treatment for multiple sclerosis patients in the Czech republic from 2013 to 2016: Data from the national registry ReMuSD Horakova, P Rockova, J Jircikova, et al.
Journal of Water Process Engineering|November 21, 2022
Biocatalyst developed with recovered iron-rich minerals enhances the biotransformation of SARS-CoV-2 antiviral drugs in anaerobic bioreactorsFrancisco J Mares-Carbajal, M Carolina Espinosa-Arzate, Luis A Ramírez-Montoya, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
RNA- and ATAC-sequencing Reveals a Unique Z K Chatila, A Yadav, J Mares, et al.
Vaccine|July 16, 2013
Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10-17 years of age: results from a randomised, controlled, double-blind trial, R R Abu-Elyazeed, T Heineman, et al.
Physical Review Letters|September 28, 2010
Midrapidity antiproton-to-proton ratio in pp collisons at sqrt[s]=0.9 and 7 TeV measured by the ALICE experimentK Aamodt, N Abel, U Abeysekara, et al.
Pageof 24

Showing results (231-240 of 236) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 236 results.
European Journal of Neurology|March 3, 2011
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosisA Novotna, J Mares, S Ratcliffe, et al.
Multiple Sclerosis and Related Disorders|August 11, 2019
Initiation of first disease-modifying treatment for multiple sclerosis patients in the Czech republic from 2013 to 2016: Data from the national registry ReMuSD Horakova, P Rockova, J Jircikova, et al.
Journal of Water Process Engineering|November 21, 2022
Biocatalyst developed with recovered iron-rich minerals enhances the biotransformation of SARS-CoV-2 antiviral drugs in anaerobic bioreactorsFrancisco J Mares-Carbajal, M Carolina Espinosa-Arzate, Luis A Ramírez-Montoya, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
RNA- and ATAC-sequencing Reveals a Unique Z K Chatila, A Yadav, J Mares, et al.
Vaccine|July 16, 2013
Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10-17 years of age: results from a randomised, controlled, double-blind trial, R R Abu-Elyazeed, T Heineman, et al.
Physical Review Letters|September 28, 2010
Midrapidity antiproton-to-proton ratio in pp collisons at sqrt[s]=0.9 and 7 TeV measured by the ALICE experimentK Aamodt, N Abel, U Abeysekara, et al.
Pageof 24